Mechanisms Used by Human Papillomaviruses to Escape the Host Immune ResponseShreya Kanodia, W. Martin Kast, Laura Fahey|Current Cancer Drug Targets|2007Cited by 239
Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesionsShreya Kanodia, W. Martin Kast|International Journal of Cancer|2007Cited by 69
Expression of LIGHT/TNFSF14 Combined with Vaccination against Human Papillomavirus Type 16 E7 Induces Significant Tumor RegressionShreya Kanodia, W. Martin Kast, Lies Bogaert et al.|Cancer Research|2010Cited by 44
Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stagesAndrew Gray, W. Martin Kast, María de la Luz García-Hernández et al.|Vaccine|2009Cited by 37
Peptide-based vaccines for cancer: realizing their potentialShreya Kanodia, W. Martin Kast|Expert Review of Vaccines|2008Cited by 25